Navigation Links
Baylor University Medical Center activates Allscripts electronic health record system

CHICAGO, Feb. 13, 2013 /PRNewswire/ -- Baylor University Medical Center ("Baylor Dallas"), the flagship of the Baylor Health Care System, has successfully implemented the Allscripts (NASDAQ: MDRX) Sunrise Clinical Manager™ (SCM) for its Dallas campus. Sunrise Clinical Manager, an acute care Electronic Health Record, will help Baylor Dallas, one of America's Best Hospitals according to U.S. News & World Report, to transform its organization by providing the capabilities for Baylor to deliver better quality, safer care at a lower cost. This is the eleventh Baylor Health Care System affiliated-facility to implement Sunrise Clinical Manager.

The successful implementation on the Dallas campus included the Baylor Hamilton Heart and Vascular Hospital. One week into the activation, more than 78,000 orders were entered electronically into the SCM system by more than 700 physicians.

Sunrise Clinical Manager provides state-of-the-art Computerized Provider Order Entry (CPOE), as well as an integrated pharmacy, knowledge-based medication administration, a patient portal and acute and critical care solutions. Baylor Health Care System uses Sunrise Access Manager™, Sunrise Scheduling™, Sunrise Acute Care™, Sunrise Clinical Analytics™, Sunrise Pharmacy™ and Sunrise KBMA™. The combination of these solutions will help Baylor Dallas to improve patient care and increase efficiencies.

"Implementing an Electronic Health Record system has been the most significant culture change in our 110-year history," said Irving D. Prengler , M.D, CMO and VP of Medical Affairs at Baylor Dallas. "This is the beginning of a great journey to improve patient care and to enhance the work lives of our clinicians." 

Baylor Dallas is a nationally-recognized, faith-based nonprofit hospital that cares for more than 300,000 patients each year. The hospital has 1,065 licensed beds and is a major patient care, teaching and research center for the Southwest.

"The successful implementation at Baylor Dallas can be attributed to the combined efforts of its physicians, nurses and information system department," said Paul Black , President and Chief Executive Officer of Allscripts. "The use of Sunrise Clinical Manager will help Baylor Dallas continue to offer high quality patient care for its community."

About Allscripts

Allscripts (NASDAQ:  MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About Baylor Health Care System

Baylor Health Care System (Baylor) is a nonprofit, faith-based supporting organization providing services to a network of acute care hospitals and related health care entities that provide patient care, medical education, research and community service. Baylor recorded more than 2.8 million patient encounters, $4.1 billion in total operating revenue, $5.3 billion in total assets and $502 million in community benefit in fiscal year 2011 (as reported to the Texas Department of State Health Services).  Baylor's network of more than 300 access points includes 30 owned/operated/ ventured/affiliated hospitals; joint ventured ambulatory surgical centers; satellite outpatient locations; senior centers and more than 190 HealthTexas Provider Network physician clinics.

© 2013 Allscripts Healthcare, LLC. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are either registered trademarks or trademarks of Allscripts Healthcare, LLC in the United States and/or other countries.  All other trademarks are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that the expected synergies, efficiencies and cost savings of the merger with Eclipsys Corporation ("Eclipsys") will not be realized, or will not be realized within the expected time period; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risk that the Allscripts and Eclipsys businesses will not be integrated successfully; competition within the industries in which we operate; failure to achieve certification under the Health Information Technology for Economic and Clinical Health Act could result in increased development costs, a breach of some customer obligations and could put us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; the outcome of any legal proceeding that has been or may be instituted against us; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; and breach of our security by third parties. See our Annual Report on Form 10-K for 2011 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.

SOURCE Allscripts Healthcare Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
2. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
3. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
4. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
5. Guangzhous Sun Yat-sen University Cancer Center Debuts MOSAIQ in the Chinese Platform
6. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
7. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
8. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
9. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
10. Oregon State University Launches New Online Learning System For Pharmacy Managers
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
(Date:10/13/2015)... , Oct. 13, 2015  A minimally-invasive treatment just ... the United States.  After more than 10 years of ... 9 approved the use of High Intensity Focused Ultrasound ... cells while protecting surrounding tissue and minimizing chances for ... George Suarez , a pioneering Miami ...
(Date:10/13/2015)... N.J. , Oct. 13, 2015  ContraVir ... the "Company"), a biopharmaceutical company focused on the ... announced the closing of its previously announced underwritten ... stock and warrants to purchase up to 3,000,000 ... fixed combined price to the public of $3.00. ...
(Date:10/13/2015)... , Oct. 13, 2015  Measurement in accountable ... and balancing financial incentives, but gaps in measurement ... care and health systems. A new, peer-reviewed ... Managed Care explores measurement gaps for ... sets. --> --> ...
Breaking Medicine Technology:
(Date:10/13/2015)... , ... October 13, 2015 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... 20th Annual Gala, A Legacy of Hope; A Commitment to Cure last night ...
(Date:10/13/2015)... ... October 13, 2015 , ... Though trick-or-treating ... friendly confines of their home. Whether it's making fun pre or post trick-or-treat ... from Florida Dairy Farmers. , Recipe 1: Green Chile Queso Dip with ...
(Date:10/13/2015)... Los Angeles, CA (PRWEB) , ... October 13, 2015 , ... ... worldwide theatrical premiere at Laemmle Music Hall in Beverly Hills October 2 - 8, ... Month. Qualifying for Academy Award® consideration, the film takes us through the lives of ...
(Date:10/13/2015)... , ... October 13, 2015 , ... The added calories ... goblin this Halloween. So what is a parent to do? Registered dietitians from ... to stay trim this time of year. , “Halloween is a high-calorie holiday,” ...
(Date:10/13/2015)... ... 13, 2015 , ... Purdue University announced Tuesday (Oct. 13) ... aimed at enhancing Purdue’s life sciences research and graduate education. The initiative comes ... The investment will result in cohesive efforts across several colleges and is designed ...
Breaking Medicine News(10 mins):